Amplification of 7p12 is Associated with Pathologic Non-Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
In conclusion, 7p12 amplification may predict non-response to NAC and worse survival in MIBC. Multicenter, prospective trials with sufficient statistical power may further fortify these findings.
PMID: 31843500 [PubMed - as supplied by publisher]
Source: The American Journal of Pathology - Category: Pathology Authors: Pichler R, Lindner AK, Compérat E, Obrist P, Schäfer G, Todenhöfer T, Horninger W, Culig Z, Untergasser G Tags: Am J Pathol Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Chemotherapy | Gastroschisis Repair | Genetics | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Pathology | Statistics | Study